Pharmaceutical giants prepare for battle with new corona variant

A number of pharmaceutical companies have started investigating how they can adapt their existing vaccines or design new ones to tackle the new Covid-19 variant, which is spreading rapidly.

Photo: Jeff Pachoud/AFP/Ritzau Scanpix

Researchers all over the world are fighting tooth and nail to identify chinks in the armor of the new coronavirus mutation, called the Omicron variant, which has spread fear throughout the population and the markets over the past few days.

Moderna, Pfizer/Biontech, Johnson & Johnson and Astrazeneca, which have all developed first-generation Covid-19 vaccines, have all started sequencing the new variant, reports the Financial Times.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Coloplast upgrades growth expectations following acquisition

Medtech firm Coloplast’s Q1 report for 2021/2022 brings a slight upward adjustment of the reported revenue growth outlook due to foreign exchange developments. Coloplast’s acquisition of Atos Medical is expected to contribute around 6 percent to organic growth.

Demant's surgical division loses president of 13 years

Oticon Medical, the implants division at hearing group Demant, is saying goodbye to President Jes Olsen, who is exiting his role in March after having spearheaded the business leg since 2008. Demant CEO Søren Nielsen is stepping in temporarily until a replacement is found.

Hearing aid market in US grew by 37 percent in 2021

Hearing aid manufacturers have had a good year following one of the worst in their recorded history, as sales in the US have gone up by 37 percent. The progress is mainly driven by the recovery of independent retailers, whereas public sales channel Veterans Affairs still lags behind.

Further reading

Related articles

Latest news

See all jobs